Literature DB >> 21098275

Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis.

Curtis J Henry1, Andriy Marusyk, Vadym Zaberezhnyy, Biniam Adane, James DeGregori.   

Abstract

Aging is associated with the functional decline of cells, tissues, and organs. At the same time, age is the single most important prognostic factor in the development of most human cancers, including chronic myelogenous and acute lymphoblastic leukemias initiated by Bcr-Abl oncogenic translocations. Prevailing paradigms attribute the association between aging and cancers to the accumulation of oncogenic mutations over time, because the accrual of oncogenic events is thought to be the rate-limiting step in initiation and progression of cancers. Conversely, aging-associated functional decline caused by both cell-autonomous and non-cell-autonomous mechanisms is likely to reduce the fitness of stem and progenitor cell populations. This reduction in fitness should be conducive for increased selection of oncogenic mutations that can at least partially alleviate fitness defects, thereby promoting the initiation of cancers. We tested this hypothesis using mouse hematopoietic models. Our studies indicate that the dramatic decline in the fitness of aged B-lymphopoiesis coincides with altered receptor-associated kinase signaling. We further show that Bcr-Abl provides a much greater competitive advantage to old B-lymphoid progenitors compared with young progenitors, coinciding with restored kinase signaling pathways, and that this enhanced competitive advantage translates into increased promotion of Bcr-Abl-driven leukemias. Moreover, impairing IL-7-mediated signaling is sufficient to promote selection for Bcr-Abl-expressing B progenitors. These studies support an unappreciated causative link between aging and cancer: increased selection of oncogenic mutations as a result of age-dependent alterations of the fitness landscape.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098275      PMCID: PMC3003039          DOI: 10.1073/pnas.1005486107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Age-related changes in lymphocyte development and function.

Authors:  Phyllis Jean Linton; Kenneth Dorshkind
Journal:  Nat Immunol       Date:  2004-02       Impact factor: 25.606

2.  Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment.

Authors:  E M Sherwood; B B Blomberg; W Xu; C A Warner; R L Riley
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

3.  Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data.

Authors:  M Vickers
Journal:  Br J Haematol       Date:  1996-07       Impact factor: 6.998

4.  Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

Authors:  S Zhang; E S Ramsay; B A Mock
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation.

Authors:  Simona Parrinello; Jean-Philippe Coppe; Ana Krtolica; Judith Campisi
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

6.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

7.  Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification.

Authors:  R Pelanda; S Schwers; E Sonoda; R M Torres; D Nemazee; K Rajewsky
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

8.  Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors.

Authors:  R P Stephan; D A Lill-Elghanian; P L Witte
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

9.  Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation.

Authors:  C Justin Van De Wiele; Julie H Marino; Bryce W Murray; Stephen S Vo; Michael E Whetsell; T Kent Teague
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

View more
  39 in total

1.  Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia.

Authors:  Andrii I Rozhok; Jennifer L Salstrom; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

Review 2.  The ageing haematopoietic stem cell compartment.

Authors:  Hartmut Geiger; Gerald de Haan; M Carolina Florian
Journal:  Nat Rev Immunol       Date:  2013-04-15       Impact factor: 53.106

3.  Evolved tumor suppression: why are we so good at not getting cancer?

Authors:  James DeGregori
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

Review 4.  Acute lymphoblastic leukemia and developmental biology: a crucial interrelationship.

Authors:  Elena Campos-Sanchez; Amparo Toboso-Navasa; Isabel Romero-Camarero; Marcos Barajas-Diego; Isidro Sanchez-García; César Cobaleda
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

5.  What can ecology teach us about cancer?

Authors:  Irina Kareva
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

6.  Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.

Authors:  Andrii I Rozhok; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

Review 7.  Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?

Authors:  J DeGregori
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

8.  The evolution of lifespan and age-dependent cancer risk.

Authors:  Andrii I Rozhok; James DeGregori
Journal:  Trends Cancer       Date:  2016-10

Review 9.  Impact of genomic damage and ageing on stem cell function.

Authors:  Axel Behrens; Jan M van Deursen; K Lenhard Rudolph; Björn Schumacher
Journal:  Nat Cell Biol       Date:  2014-03       Impact factor: 28.824

10.  Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors.

Authors:  Curtis J Henry; Matias Casás-Selves; Jihye Kim; Vadym Zaberezhnyy; Leila Aghili; Ashley E Daniel; Linda Jimenez; Tania Azam; Eoin N McNamee; Eric T Clambey; Jelena Klawitter; Natalie J Serkova; Aik Choon Tan; Charles A Dinarello; James DeGregori
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.